SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-015285
Filing Date
2021-04-30
Accepted
2021-04-30 16:22:31
Documents
4
Period of Report
2021-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10023585x1_def14a.htm DEF 14A 909021
2 logo_rocketpharma.jpg GRAPHIC 25772
3 nc10023585x1_pc01.jpg GRAPHIC 540600
4 nc10023585x1_pc02.jpg GRAPHIC 540615
  Complete submission text file 0001140361-21-015285.txt   2433947
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36829 | Film No.: 21878419
SIC: 2834 Pharmaceutical Preparations